LifeVantage Corporation (LFVN)
The price, the headline numbers and the latest news, in one place.
LifeVantage Corporation (LFVN) Stock Price, Analysis & Data
| Bid | 4.61 |
| Market Cap | 79.4M |
| Revenue (ttm) | 183M |
| Net Income (ttm) | 5.07M |
| 0.76 | |
| 0.4 | |
| 15.85 | |
| 16.4 | |
| P/B (ttm) | 2.36 |
| P/S (ttm) | 0.43 |
| Earnings Date | Nov 3, 2026 |
| Ask | 8 |
| Volume | 105,869 |
| Avg. Volume (20D) | 219,661 |
| Open | 6.20 |
| Previous Close | 6.25 |
| Day's Range | 6.20 - 6.75 |
| 52-Week Range | 3.90 - 12.10 |
| Analyst | Buy |
| Price Target | 7.5 (18.3%) |
| Dividends | $0.20 (3.21%) |
| Ex-Dividend Date | Sep 1, 2026 |
About LFVN
LifeVantage Corporation engages in the identification, research, development, formulation, and sale of advanced nutrigenomic activators, dietary supplements, nootropics, weight management, gut health, and skin and hair care products in the United States and internationally. It offers Protandim, a dietary supplement; LifeVantage Omega+, a dietary supplement that combines DHA and EPA Omega-3 and Omega-7 fatty acids, and vitamin D3; LifeVantage ProB...
Financial Performance
In 2026, LifeVantage's revenue was 182.59M, a decrease of -20.1% compared to the previous year's 228.53M. Earnings were 5.07M, a decrease of -48.27%.
Financial StatementsAnalyst Forecast
According to 2 analyst ratings, the average rating for LFVN stock is "Buy". The 12-month stock price forecast is 7.5, which is upside of 18.3% from the latest price.
Stock ForecastsEarnings Surprise
- Revenue of $42.38M misses estimates by $0, with -23.11% YoY decline.
- EPS of 0.11 misses estimates by -0.02, with -35.29% YoY decline.
Analysts project revenue of ... Upgrade
